Inactive Instrument

Wise Oakwood Ventures Inc Share Price Toronto S.E.

Equities

WOWp

CA9772561069

Healthcare Facilities & Services

End-of-day quote Toronto S.E.
- - Intraday chart for Wise Oakwood Ventures Inc
Sales 2022 18.93 0 1.57K Sales 2023 25.19 0 2.09K Capitalization 196M 0 16.31B
Net income 2022 -17M - -1.41B Net income 2023 -34M - -2.83B EV / Sales 2022 24,49,963 x
Net cash position 2022 113M 0 9.42B Net cash position 2023 87.77M 0 7.3B EV / Sales 2023 43,04,730 x
P/E ratio 2022
-9.39 x
P/E ratio 2023
-5.68 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 98.36%
More Fundamentals * Assessed data

Latest transcript on Wise Oakwood Ventures Inc

Managers TitleAgeSince
Chief Executive Officer 67 01/21/01
Director of Finance/CFO 54 16/23/16
Chief Tech/Sci/R&D Officer - 01/18/01
Members of the board TitleAgeSince
Chief Executive Officer 67 01/21/01
Director/Board Member 62 16/19/16
Director/Board Member 66 16/20/16
More insiders
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.
Calendar
06/06/2024 - ACVIM Forum
More about the company